MedTrace Logo

Long-term Observation Of Patient Engagement in Automated Insulin Delivery

NCT06858475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 453

Last updated 2025-06-20

No results posted yet for this study

Summary

The purpose of this study is to assess the long-term evolution of patient interaction with the CONTROL-IQ (Tandem™) hybrid closed-loop (HCL) system in individuals with type 1 diabetes over 24 months. Specifically, the study examines user-initiated boluses and carbohydrate announcements to determine whether initially low-engagement users increase their involvement over time or, conversely, whether highly engaged users gradually rely more on automation.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

CONTROL-IQ (Tandem™)

interaction with the CONTROL-IQ (Tandem™) hybrid closed-loop (HCL) system in individuals with type 1 diabetes

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Coralie AMADOU, MD · Centre Hospitalier Sud Francilien

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-20
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06858475 on ClinicalTrials.gov